| # | Title | Journal | Year | Citations |
|---|
| 1 | Diagnosis of monoclonal gammopathy of renal significance | Kidney International | 2015 | 339 |
| 2 | The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group | Nature Reviews Nephrology | 2019 | 330 |
| 3 | Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial | Lancet Oncology, The | 2017 | 320 |
| 4 | How I treat monoclonal gammopathy of renal significance (MGRS) | Blood | 2013 | 259 |
| 5 | Second primary malignancies with lenalidomide therapy for newly diagnosed myeloma: a meta-analysis of individual patient data | Lancet Oncology, The | 2014 | 256 |
| 6 | Taxane resistance in breast cancer: Mechanisms, predictive biomarkers and circumvention strategies | Cancer Treatment Reviews | 2012 | 221 |
| 7 | Olive oil intake is inversely related to cancer prevalence: a systematic review and a meta-analysis of 13800 patients and 23340 controls in 19 observational studies | Lipids in Health and Disease | 2011 | 213 |
| 8 | Update on Treatment Recommendations From the Fourth International Workshop on Waldenström's Macroglobulinemia | Journal of Clinical Oncology | 2009 | 207 |
| 9 | Once-per-week selinexor, bortezomib, and dexamethasone versus twice-per-week bortezomib and dexamethasone in patients with multiple myeloma (BOSTON): a randomised, open-label, phase 3 trial | Lancet, The | 2020 | 188 |
| 10 | Treatment of light chain (AL) amyloidosis with the combination of bortezomib and dexamethasone | Haematologica | 2007 | 179 |
| 11 | Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG) | Leukemia | 2009 | 176 |
| 12 | First-stroke recovery process: The role of family social support | Archives of Physical Medicine and Rehabilitation | 2000 | 175 |
| 13 | Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents | Haematologica | 2007 | 160 |
| 14 | VMP (Bortezomib, Melphalan, and Prednisone) Is Active and Well Tolerated in Newly Diagnosed Patients With Multiple Myeloma With Moderately Impaired Renal Function, and Results in Reversal of Renal Impairment: Cohort Analysis of the Phase III VISTA Study | Journal of Clinical Oncology | 2009 | 154 |
| 15 | Blood Pressure Reduction and Secondary Stroke Prevention | Hypertension | 2017 | 140 |
| 16 | Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: consensus statement | Leukemia | 2011 | 108 |
| 17 | Patients With Apparently Nonfunctioning Adrenal Incidentalomas May Be at Increased Cardiovascular Risk Due to Excessive Cortisol Secretion | Journal of Clinical Endocrinology and Metabolism | 2014 | 108 |
| 18 | Home blood pressure monitoring: methodology, clinical relevance and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension | Journal of Hypertension | 2021 | 82 |
| 19 | Impact of Maternal Diabetes on Epigenetic Modifications Leading to Diseases in the Offspring | Experimental Diabetes Research | 2012 | 80 |
| 20 | Propranolol Versus Metoprolol for Treatment of Electrical Storm in Patients With Implantable Cardioverter-Defibrillator | Journal of the American College of Cardiology | 2018 | 80 |
| 21 | Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study | Journal of the American College of Cardiology | 2000 | 71 |
| 22 | Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation | Oncologist | 2017 | 62 |
| 23 | Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: Report of 2 cases with clinical implications | Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology | 2012 | 60 |
| 24 | Prognostic Value of Iodine-123-Metaiodobenzylguanidine Myocardial Uptake and Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy | American Journal of Cardiology | 2005 | 58 |
| 25 | XELIRI-bevacizumab versus FOLFIRI-bevacizumab as first-line treatment in patients with metastatic colorectal cancer: a Hellenic Cooperative Oncology Group phase III trial with collateral biomarker analysis | BMC Cancer | 2012 | 57 |
| 26 | Evaluation of the prognostic and predictive value of HER family mRNA expression in high-risk early breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study | British Journal of Cancer | 2008 | 56 |
| 27 | Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials | Leukemia | 2020 | 54 |
| 28 | Integrative analysis of the genomic and transcriptomic landscape of double-refractory multiple myeloma | Blood Advances | 2020 | 54 |
| 29 | Cancer in pregnancy: disentangling treatment modalities | ESMO Open | 2016 | 51 |
| 30 | Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer | Pharmaceuticals | 2012 | 49 |
| 31 | Improved Outcome of High-Risk Early HER2 Positive Breast Cancer With High CXCL13-CXCR5 Messenger RNA Expression | Clinical Breast Cancer | 2012 | 49 |
| 32 | Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations | Endocrine | 2021 | 49 |
| 33 | The evolving role of lenalidomide in the treatment of hematologic malignancies | Expert Opinion on Pharmacotherapy | 2007 | 46 |
| 34 | All about KRAS for clinical oncology practice: Gene profile, clinical implications and laboratory recommendations for somatic mutational testing in colorectal cancer | Cancer Treatment Reviews | 2011 | 45 |
| 35 | Monitoring of Arterial Stiffness Indices by Applanation Tonometry and Pulse Wave Analysis: Reproducibility at Low Blood Pressures | Journal of Clinical Monitoring and Computing | 2003 | 40 |
| 36 | Endometrial Cancer: What Is New in Adjuvant and Molecularly Targeted Therapy? | Obstetrics and Gynecology International | 2010 | 40 |
| 37 | New Aspects on the Role of Blood Pressure and Arterial Stiffness in Mechanical Assistance by Intra-aortic Balloon Pump: In-vitro Data and Their Application in Clinical Practice | Artificial Organs | 2004 | 39 |
| 38 | Increased Serum Lactate Dehydrongenase Should Be Included Among the Variables That Define Very-High-Risk Multiple Myeloma | Clinical Lymphoma, Myeloma and Leukemia | 2011 | 39 |
| 39 | Sleep During “Lockdown” in the COVID-19 Pandemic | International Journal of Environmental Research and Public Health | 2020 | 39 |
| 40 | Diabetes and COVID-19; A Bidirectional Interplay | Frontiers in Endocrinology | 2022 | 38 |
| 41 | Clinicopathological features of ovarian carcinosarcomas: a single institution experience | Gynecologic Oncology | 2005 | 35 |
| 42 | Treatment of early uterine sarcomas: disentangling adjuvant modalities | World Journal of Surgical Oncology | 2009 | 35 |
| 43 | DNA damage, tumor mutational load and their impact on immune responses against cancer | Annals of Translational Medicine | 2016 | 35 |
| 44 | Endocrine-related adverse conditions in patients receiving immune checkpoint inhibition: an ESE clinical practice guideline | European Journal of Endocrinology | 2022 | 35 |
| 45 | Thyroid disorders and cardiovascular manifestations: an update | Endocrine | 2022 | 33 |
| 46 | How we treat endocrine complications of immune checkpoint inhibitors | ESMO Open | 2021 | 32 |
| 47 | Early and late endocrine complications of COVID-19 | Endocrine Connections | 2021 | 32 |
| 48 | Hsp90 in the continuum of breast ductal carcinogenesis: Evaluation in precursors, preinvasive and ductal carcinoma lesions | BMC Cancer | 2010 | 31 |
| 49 | Sleepiness, fatigue, anxiety and depression in Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea – Overlap – Syndrome, before and after continuous positive airways pressure therapy | PLoS ONE | 2018 | 31 |
| 50 | Developments in the systemic treatment of endometrial cancer | Critical Reviews in Oncology/Hematology | 2011 | 29 |
